Regulatory delays, confusing FDI policy and pricing norms are crippling the industry
MUST READ
Pause slide
Global pharmaceutical companies have increased their focus on high-growth emerging markets as a consequence of severe…
An alliance like this has ended up creating the 15th largest drug company in the world. This is a significant…
